[1] Powell EE, Wong VW, Rinella M. Non-alcoholic fatty liver disease. Lancet,2021,397(10290):2212-2224. [2] Liu H, Xu J, Li H,et al. Network pharmacology-based investigation to explore the effect and mechanism of Erchen decoction against the nonalcoholic fatty liver disease. Anat Rec (Hoboken),2021,304(11):2605-2619. [3] Guo J. Research progress on prevention and treatment of glucolipid metabolic disease with integrated traditional Chinese and Western medicine. Chin J Integr Med, 2017,23(6):403-409. [4] 柴颖,郭宁,么焕新,等. 幽门螺杆菌根除治疗对非酒精性脂肪性肝病脂代谢及胰岛素抵抗的影响. 中华医院感染学杂志,2021,31(9):1319-1323. [5] Lan T, Yu Y, Zhang J, et al. Cordycepin ameliorates nonalcoholic steatohepatitis by activation of the AMP-activated protein kinase signaling pathway. Hepatology,2021,74(2):686-703. [6] 公培强,池晓玲,蒋元烨. 运用疏肝化瘀疗法治疗脂肪肝经验. 中华中医药学刊,2019,37(3):559-562. [7] 中华医学会肝病学分会脂肪肝和酒精性肝病学组,中国医师协会脂肪性肝病专家委员会.非酒精性脂肪性肝病防治指南(2018年更新版).实用肝脏病杂志,2018,21(2):177-186. [8] 中国中西医结合学会消化系统疾病专业委员会. 非酒精性脂肪性肝病的中西医结合诊疗共识意见. 中国中西医结合杂志,2011,31(2):155-158. [9] 商洪才,王保和,张伯礼.中药新药证候及疗效评价.中药新药与临床药理,2004,15(5):365-368. [10] Makri E, Goulas A, Polyzos SA. Epidemiology,pathogenesis, diagnosis and emerging treatment of nonalcoholic fatty liver disease. Arch Med Res,2021,52(1):25-37. [11] Kazankov K, Jørgensen SMD, Thomsen KL,et al. The role of macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Nat Rev Gastroenterol Hepatol,2019,16(3):145-159. [12] Younossi ZM. Non-alcoholic fatty liver disease - A global public health perspective. J Hepatol. 2019,70(3):531-544. [13] Yang JM, Sun Y, Wang M,et al. Regulatory effect of a Chinese herbal medicine formula on non-alcoholic fatty liver disease. World J Gastroenterol, 2019,25(34):5105-5119. [14] Huang CY, Wu MY, Wang HC,et al. Chinese berbal medicine decreases incidence of cirrhosis in patients with non-alcoholic fatty liver disease in Taiwan: A propensity score-matched cohort study. J Altern Complement Med,2021,27(7):596-605. [15] Engds P, Araujo BP, Rodrigues KL, et al. Simvastatin improves microcirculatory function in nonalcoholic fatty liver disease and downregulates oxidative and ALE-RAGE stress. Nutrients,2022,14(3):716. [16] Hu J, Wang H, Li X,et al. Fibrinogen-like protein 2 aggravates nonalcoholic steatohepatitis via interaction with TLR4, eliciting inflammation in macrophages and inducing hepatic lipid metabolism disorder. Theranostics,2020,10(21):9702-9720. [17] 王芳,高晓霞,汪庆强. 黄连解毒汤联合益生菌制剂对非酒精性脂肪性肝炎患者中医症候积分和肠道菌群平衡的影响. 实用肝脏病杂志,2022,25(2):235-238. [18] Xu X, Li L, Zhang Y,et al. Hypolipidemic effect of Alisma orientale (Sam) Juzep on gut microecology and liver transcriptome in diabetic rats. PLoS One, 2020,15(10):e0240616. [19] Liu S, Li F, Zhang X. Structural modulation of gut microbiota reveals Coix seed contributes to weight loss in mice. Appl Microbiol Biotechnol,2019,103(13):5311-5321. [20] Cassiem W, de Kock M. The anti-proliferative effect of apricot and peach kernel extracts on human colon cancer cells in vitro. BMC Complement Altern Med,2019,19(1):32. |